Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder.
Saved in:
| Title: | Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder. |
|---|---|
| Authors: | Huang W; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China., Wang L; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China., Xia J; Department of Neurology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China., Li W; Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China., Wang M; Department of Ophthalmology and Vision Science, Eye and ENT Hospital, Fudan University, Shanghai, China., Yu J; Department of Ophthalmology and Vision Science, Eye and ENT Hospital, Fudan University, Shanghai, China., Li Q; Department of Rehabilitation Medicine, Jing'an District Center Hospital of Shanghai, Fudan University, Shanghai, China., Wang B; Department of Neurology, Jing'an District Center Hospital of Shanghai, Fudan University, Shanghai, China., Pan J; Department of Neurology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China., Du L; Department of Neurology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China., Ma J; Department of Neurology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China., Tan H; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China., Chang X; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China., Lu C; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China., Zhao C; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China., Lu J; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China., Zhou L; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China., ZhangBao J; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China., Quan C; Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; National Center for Neurological Disorders, Shanghai, China.; Huashan Rare Disease Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. |
| Corporate Authors: | Pan-Yangtze River Delta Alliance for Demyelinating Disease |
| Source: | European journal of neurology [Eur J Neurol] 2022 Aug; Vol. 29 (8), pp. 2343-2354. Date of Electronic Publication: 2022 Apr 27. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1468-1331 |
|---|---|
| DOI: | 10.1111/ene.15355 |
